AA
NARI

AlphaCentric Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

AlphaCentric Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,000
Closed -$722K – 242
2024
Q2 		$722K Sell
15,000
-48,000
-76% -$2.13M 0.53% 62
2024
Q1 		$3.02M Buy
63,000
+58,000
+1,160% +$3.1M 1.82% 10
2023
Q4 		$325K Buy
+5,000
New +$301K 0.22% 92

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AlphaCentric Advisors's NARI Position: Q3 2024 in Review

AlphaCentric Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2024, closing a stake of 15,000 shares — an estimated $722K sold.

AlphaCentric Advisors first reported a position in NARI in Q4 2023 and held it in 3 quarters. The position peaked at $3.02M in Q1 2024. 243 funds tracked by Wall St. Rank hold NARI as of Q3 2024.

  • AlphaCentric Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • AlphaCentric Advisors sold 15,000 Inari Medical, Inc. Common Stock shares in Q3 2024, an estimated $722K.
  • AlphaCentric Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • AlphaCentric Advisors's Inari Medical, Inc. Common Stock position peaked at $3.02M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2024.

Based on AlphaCentric Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.